Large Optical Asymmetry in Silver Nanoparticle Assemblies Enabled by CH−π Interaction-Mediated Chirality Transfer
作者:Ye Wang、Rongjuan Liu、Zongze Zhang、Jingjing Wei、Zhijie Yang
DOI:10.1021/jacs.2c11639
日期:——
grafted on Ag nanoparticles are served as the hydrogen donor and acceptor, respectively. The opticalasymmetry g-factor of the chiral assemblies of plasmonic nanoparticles is strongly dependent on the molecular weight of the polystyrene ligand, the core structure of the molecule, and the aliphatic chain length of the chiral molecule. Importantly, we explore a molecular mixing strategy to enhance the asymmetry
D-serine transport antagonist for treating psychosis
申请人:DR. DANIEL JAVITT
公开号:US20020183390A1
公开(公告)日:2002-12-05
Method and composition for augmenting NMDA receptor mediated neurotransmission involving use of a D-serine transport inhibitor.
使用 D-丝氨酸转运抑制剂增强 NMDA 受体介导的神经传递的方法和组合物。
Synthesis of Diacetylene-Containing Peptide Building Blocks and Amphiphiles, Their Self-Assembly and Topochemical Polymerization in Organic Solvents
作者:Eike Jahnke、Jan Weiss、Sonja Neuhaus、Tobias N. Hoheisel、Holger Frauenrath
DOI:10.1002/chem.200801668
日期:2009.1.2
hydrogen‐bonding sites gave rise to high aspect ratio nanoscopic fibrils with helical superstructures but, in contrast to the related macromonomers, did not lead to uniform supramolecular polymers. The UV‐induced topochemicalpolymerization within the β‐sheet aggregates was successful, proving parallel β‐strand orientation and highlighting the effect of the number and pattern of N‐H⋅⋅⋅OC hydrogen‐bonding sites
Living and enantiomer-selective polymerization of allene initiated by Ni complex containing chiral phosphine
作者:Hai Zhu、Shizhong Luo、Zongquan Wu
DOI:10.1016/j.cclet.2018.03.002
日期:2019.1
Abstract A new allylnickel(II) complex ([S(R)]-N-[(1S)-2-(diphenylphosphino)-1-phenylethyl]-2-methyl-2-propanesulfinamide)(2,2,2-trifluoroacetato-κO)(π-allyl)nickel (2) was designed and prepared by usingchiral phosphine. 2 was revealed to efficiently initiate the polymerization of l - and d -N-(1-(dodecylamino)-1-oxopropan-2-yl)-4-(propa-1,2-dien-1-yloxy)-benzamide ( l -1 and d -1) in a living/controlled